Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.09T
Market cap1.09T
Price-Earnings ratio
41.49
Price-Earnings ratio41.49
Dividend yield
0.56%
Dividend yield0.56%
Average volume
2.53M
Average volume2.53M
High today
$1,160.82
High today$1,160.82
Low today
$1,134.44
Low today$1,134.44
Open price
$1,146.86
Open price$1,146.86
Volume
2.55M
Volume2.55M
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,156.51. The company's market cap stands at 1.09T, with a P/E ratio of 41.49 and a dividend yield of 0.56%.

During the trading session on 2026-07-16, Eli Lilly(LLY) shares reached a daily high of $1,160.82 and a low of $1,134.44. At a current price of $1,156.51, the stock is +1.9% higher than the low and still -0.4% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 2.55M, versus its average volume of 2.53M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

LLY News

Barron's 1h
This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks - Barron's

...

This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks - Barron's
Benzinga 6h
AtaiBeckley Stock Skyrockets 65% After-Hours on Reported Eli Lilly Acquisition Talks

AtaiBeckley Inc. (NASDAQ:ATAI) shares are trending on Thursday. Lilly Eyes Acquisition At A Premium According to the report, Lilly is negotiating the acquisit...

AtaiBeckley Stock Skyrockets 65% After-Hours on Reported Eli Lilly Acquisition Talks
TipRanks 9h
Eli Lilly in talks to acquire AtaiBeckley, Bloomberg reports

Eli Lilly (LLY) is in discussions to acquire AtaiBeckley (ATAI) and a formal takeover could take place as soon as this week, Bloomberg’s Eyk Henning and Madison...

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

TipRanks 12h
AtaiBeckley jumps 55% after report of Eli Lilly takeover interest

18:51 EDT AtaiBeckley (ATAI) jumps 55% after report of Eli Lilly takeover interest Published first on TheFly – the ultimate source for real-time, market-moving...

TipRanks 22h
VivoSim receives $5M milestone payment from Eli Lilly

VivoSim (VIVS) announced that it has received a $5M payment from Eli Lilly (LLY). In association with its former inflammatory bowel disease drug program develop...

The Wall Street Journal 1d
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s

Novo Nordisk’s Wegovy pill is the market leader for new oral weight-loss drugs. George Frey / Bloomberg News The launch of weight-loss pills is the hottest bat...

In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
TipRanks 3d
Eli Lilly Stock Gets a Price Target Boost Heading into Earnings

Wall Street brokerage Guggenheim has raised its price target on Eli Lilly’s (LLY) stock heading into the company’s second-quarter earnings print, saying weight-...

24/7 Wall St. 3d
Prediction: 1 New Reason Eli Lilly Stock Could Still Be Headed Higher

Prediction: 1 New Reason Eli Lilly Stock Could Still Be Headed Higher By Vandita Jadeja Published Jul 13, 2:00PM EDT Quick Read LLY earns a BUY with a $1,336...

Prediction: 1 New Reason Eli Lilly Stock Could Still Be Headed Higher
Benzinga 3d
Eli Lilly Stock in Focus as Company Presents New Kisunla Data at AAIC Following Wave of Analyst Upgrades

Eli Lilly and Company (NYSE:LLY) shares are in the spotlight Monday as the company presents new data at the Alzheimer’s Association International Conference in...

Eli Lilly Stock in Focus as Company Presents New Kisunla Data at AAIC Following Wave of Analyst Upgrades
The Motley Fool 3d
Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors

Eli Lilly (LLY 2.30%) commands a market capitalization of about $1.06 trillion, and that valuation was built largely on two drugs: Mounjaro and Zepbound. Invest...

Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.